Article (Scientific journals)
Pharma-clinics le medicament du mois. Le rabeprazole (Pariet)
Louis, Edouard
2002In Revue Médicale de Liège, 57 (1), p. 53-6
Peer reviewed
 

Files


Full Text
Pharma Clinics - Rabeprazole - RMLg 2002.pdf
Publisher postprint (444.92 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Proton pomp inhibitors (PPI) have revolutionized the treatment of gastro-oesophageal reflux disease and gastro-duodenal ulcers. Rabeprazole (Pariet) is the last PPI arrived on the Belgian market. Controlled studies have shown an efficacy similar to emeprazole in the treatment of oeso-gastro-duodenal acid diseases. Rabeprazole has a favourable profile with rapid action and good safety.
Disciplines :
Gastroenterology & hepatology
Author, co-author :
Louis, Edouard  ;  Université de Liège - ULiège > Département des sciences cliniques > Hépato-gastroentérologie
Language :
French
Title :
Pharma-clinics le medicament du mois. Le rabeprazole (Pariet)
Alternative titles :
[en] Pharma-Clinics Medication of the Month. Rabeprazole (Pariet)
Publication date :
January 2002
Journal title :
Revue Médicale de Liège
ISSN :
0370-629X
eISSN :
2566-1566
Publisher :
Université de Liège. Revue Médicale de Liège, Liège, Belgium
Volume :
57
Issue :
1
Pages :
53-6
Peer reviewed :
Peer reviewed
Available on ORBi :
since 05 October 2009

Statistics


Number of views
286 (2 by ULiège)
Number of downloads
222 (2 by ULiège)

Scopus citations®
 
2
Scopus citations®
without self-citations
1

Bibliography


Similar publications



Contact ORBi